For any questions or suggestions

I accept the Privacy Policy

PRECISESADS

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases

PRECISESADS receives the support from the Innovative Medicines Initiative Joint Undertaking under GA n°115565, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution